Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 142356-62-5 | MDL No. : | MFCD16845540 |
Formula : | C7H5F2N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ARMZWEKTPLCJKD-UHFFFAOYSA-N |
M.W : | 169.13 | Pubchem ID : | 10678708 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 40.41 |
TPSA : | 54.7 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.3 cm/s |
Log Po/w (iLOGP) : | 0.79 |
Log Po/w (XLOGP3) : | 1.45 |
Log Po/w (WLOGP) : | 2.27 |
Log Po/w (MLOGP) : | 1.65 |
Log Po/w (SILICOS-IT) : | 2.13 |
Consensus Log Po/w : | 1.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.36 |
Solubility : | 0.743 mg/ml ; 0.00439 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.2 |
Solubility : | 1.06 mg/ml ; 0.00624 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.1 |
Solubility : | 0.133 mg/ml ; 0.000787 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.8 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | In methanol; water; acetonitrile for 2h; Ambient temperature; | |
78% | In ethanol at 50℃; | Method D: General procedure: To an appropriate aromatic diamino compound (1 mol. equiv.) in EtOH (4.5 ml/1 mmol starting material) was added cyanogen bromide (1.2 mol. equiv.) and resulting mixture was stirred at 50° C. till disappearance of starting material (TLC control). Then volatiles were removed in vacuo and the solid residue was re-dissolved (or suspended) in H2O. Water mixture was extracted with EtOAc (3×). Organic layer was discarded and water layer was brought to pH 9-10 (according to universal indicator paper) using 25% NH4OH or 1 M aqueous NaOH and it was extracted with EtOAc (3×). Combined organic layers were dried over MgSO4. Drying agent was removed, residue was concentrated to dryness and purified on silica gel column if needed. |
59% | Stage #1: bromocyane; 2-amino-4,5-difluoroaniline With sodium hydrogencarbonate In water; acetonitrile at 0 - 20℃; Stage #2: In ethanol for 0.25h; Heating / reflux; | 1 Step 1. The procedure used was similar to that reported in J. Med. Chem. 40:811-818, 1997. A solution of 1,2-diamino-4,5-difluorobenzene (500 mg, 3.47 mmol) in water (5 mL) was cooled to 0° C. and then treated with a solution of cyanogen bromide (0.83 mL, 4.16 mmol, 5 M in acetonitrile) and solid sodium bicarbonate (583 mg, 6.94 mmol). The solution was stirred at rt overnight and was then concentrated in vacuo. The dark residue was suspended in ethanol and heated at reflux for 15 minutes. The hot suspension was filtered, rinsing with hot ethanol, and the filtrate was concentrated in vacuo to afford 5,6-difluoro-1H-benzimidazol-2-amine (580 mg, 59%), which was used in the next step without further purification. LC-MS m/z 170.2 (MH+), ret. time 0.85 min; 1H NMR (300 MHz, DMSO-d6) δ 6.30 (br s, 2H), 7.06 (dd, 2H), 10.79 (br s, 1H). |
40% | In water; acetonitrile at 0 - 20℃; for 14h; | 140 EXAMPLE 140; Synthesis ofN4-(5-bromo-2-methylphenyl)-N5-(5,6-difluoro-lH-benzimidazol-2- yl)-lH-imidazole-4,5-dicarboxamide; Synthesis of 5,6-difluoro-lH-benzo[d]imidazol-2-amine; [00395] 4,5-Diflluorobenzene-l,2-diamine (0.651 g, 0.562 mmol, commercially available from Matrix Scientific) in acetonitrile (10 mL) and water (2 ml) at 0 0C was treated with cyanogen bromide (0.063 g, 0.6 mmol). The reaction mixture was allowed to warm to room temperature, and then stirred for 14 hours. The reaction mixture was then treated with saturated aqueous sodium hydrogen carbonate solution (50 ml) and shaken. The resulting solid was filtered off, washed with water and dried under reduced pressure to give 0.39 g of 5,6-difluoro-lH-benzo[d]imidazol-2-amine (yield, 40%). MS (EI): 186 (MH+). |
In methanol; water |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | Stage #1: With tert.-butylnitrite; copper dichloride In acetone at 20℃; for 0.333333h; Stage #2: 5,6-difluoro-1H-benzo[d]imidazol-2-amine In acetone for 2h; Heating / reflux; Stage #3: With hydrogenchloride In water; acetone at 20℃; | 2 Step 2. The procedure used was similar to that reported in J. Med. Chem. 40:811-818, 1997. To a mixture of copper(II) chloride (795 mg, 5.91 mmol) in acetone (20 mL) was added tert-butyl nitrite (0.53 mL, 4.43 mmol). The reaction mixture was stirred at rt for 20 minutes, 5,6-difluoro-1H-benzimidazol-2-amine (500 mg, 2.96 mmol) was then added, and the mixture was heated at reflux for 2 h (with additional portions of tert-butyl nitrite added every 0.5 h). The reaction mixture was then cooled to rt, treated with 2 N HCl, and extracted with ethyl acetate. The organic phase was dried over sodium sulfate and concentrated in vacuo to afford 2-chloro-5,6-difluoro-1H-benzimidazole (580 mg, 73%), which was used without further purification in the next step. LC-MS m/z 189.2 (MH+), ret. time 1.96 min; 1H NMR (300 MHz, DMSO-d6) δ 7.62 (t, 2H), 13.5 (br s, 1H). |
59% | With copper dichloride; sodium nitrite a) RT, 1 h, b) 100 deg C, 10 min; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 4-methyl-morpholine; benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate In N,N-dimethyl-formamide |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 85 percent / Fe, 1 N aq. HCl / methanol / 3 h / Ambient temperature 2: 91 percent / acetonitrile; H2O; methanol / 2 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 59 percent / aq. CuCl2, NaNO2 / a) RT, 1 h, b) 100 deg C, 10 min 2: 1.) BSA, 2.) TMSOTf / 1.) ClCH2CH2Cl, 75 deg C, 30 min, 2.) ClCH2CH2Cl, 75 deg C, 30 min 3: 55 percent / NH3 / methanol / 20 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 59 percent / aq. CuCl2, NaNO2 / a) RT, 1 h, b) 100 deg C, 10 min 2: 1.) BSA, 2.) TMSOTf / 1.) ClCH2CH2Cl, 75 deg C, 30 min, 2.) ClCH2CH2Cl, 75 deg C, 30 min 3: 89 percent / NH3 / methanol / 3 h / Ambient temperature |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 59 percent / aq. CuCl2, NaNO2 / a) RT, 1 h, b) 100 deg C, 10 min 2: 1.) BSA, 2.) TMSOTf / 1.) ClCH2CH2Cl, 75 deg C, 30 min, 2.) ClCH2CH2Cl, 75 deg C, 30 min |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 59 percent / aq. CuCl2, NaNO2 / a) RT, 1 h, b) 100 deg C, 10 min 2: 1.) BSA, 2.) TMSOTf / 1.) ClCH2CH2Cl, 75 deg C, 30 min, 2.) ClCH2CH2Cl, 75 deg C, 30 min |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2-Amino-5,6-difluorobenzimidazole (11) The filtrate and washings were evaporated to dryness and the procedure was repeated to give an additional 0.355 g of 11. The total yield of 11 was 3.755 g (91%). 1 H NMR (DMSO-d6) d 10.79 (br.s, 1,1-NH), 7.06 (dd, 2,4-H and 7-H, 3 JF-H =11.0 Hz, 4 Jf-H =7.5 Hz), 6.30 (br. s, 2,2-NH2). | ||
2-Amino-5,6-difluorobenzimidazole (11) The filtrate and washings were evaporated to dryness and the procedure was repeated to give an additional 0.355 g of 11. The total yield of 11 was 3.755 g (91%). 1 H NMR (DMSO-d6) d 10.79 (br. s, 1, 1-NH), 7.06 (dd, 2, 4-H and 7-H, 3 JF-H =11.0 Hz, 4 JF-H =7.5 Hz), 6.30 (br. s, 2, 2-NH2). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium nitrite In methanol; chloroform | 2-Chloro-5,6-difulorobenzimidazole (12) 2-Chloro-5,6-difulorobenzimidazole (12) To a stirred mixture of 40 mL of aqueous CuCl2 solution (60% by weight) and 20 mL of H2 O was added a solution of NaNO2 /H2 O (2.08 g/10 mL). Compound 11 (1.69 g, 10 mmole) was then added portionwise over 5 min. The reaction mixture was stirred at room temperature for 1 hr. An additional 30 ml of the aqueous CuCl2 solution (60% by weight) was added and the reaction mixture was heated on a steam bath for 10 min (a small amount of MeOH was added to suppress the formation of foam). The mixture was extracted with EtOAc (150 mL*2). The EtOAc solution was washed with sat. NaCl solution (100 mL*2), dried (Na2 SO4) and evaporated. The residue was chromatographed on a silica column (3*15 cm) using 2% and 3% MeOH/CHCl3 as eluants. Evaporation of the appropriate fractions gave a brownish solid. This solid was washed with Et2 O and dried to give 0.962 g of 12. The Et2 O washings were evaporated and the residue was repurified through a silica column (2*10 cm, eluted successively with 1%, 2% MeOH/CHCl3). | |
With sodium nitrite In methanol; chloroform | 2-Chloro-5,6-difluorobenzimidazole (12) 2-Chloro-5,6-difluorobenzimidazole (12) To a stirred mixture of 40 mL of aqueous CuCl2 solution (60% by weight) and 20 mL of H2 O was added a solution of NaNO2 /H2 O (2.08 g/10 mL). Compound 11 (1.69 g, 10 mmole) was then added portionwise over 5 min. The reaction mixture was stirred at room temperature for 1 hr. An additional 30 ml of the aqueous CuCl2 solution (60% by weight) was added and the reaction mixture was heated on a steam bath for 10 min (a small amount of MeOH was added to suppress the formation of foam). The mixture was extracted with EtOAc (150 mL*2). The EtOAc solution was washed with sat. NaCl solution (100 mL*2), dried (Na2 SO4) and evaporated. The residue was chromatographed on a silica column (3*15 cm) using 2% and 3% MeOH/CHCl3 as eluants. Evaporation of the appropriate fractions gave a brownish solid. This solid was washed with Et2 O and dried to give 0.962 g of 12. The Et2 O washings were evaporated and the residue was repurified through a silica column (2*10 cm, eluted successively with 1%, 2% MeOH/CHCl3). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With bromocyane In methanol; chloroform; water; acetonitrile | 2-Amino-5,6-difluorobenzimidazole (11) 2-Amino-5,6-difluorobenzimidazole (11) To a stirred solution of 4.9 mL of 5M BrCN/MeCN in 50 mL of H2 O, was added dropwise a solution of 3.515 g (24.389 mmole) of 10 in 50 mL of MeOH over 20 min. After the addition, stirring was continued at room temperature for 2 h. The reaction mixture was concentrated to ~50 mL and was extracted with EtOAc (50 mL*3). The combined EtOAc solution was back washed with 100 mL of H2 O and then discarded. The combined H2 O phase was basified with sat. NaHCO3 solution (precipitation occurred) and was extracted again with EtOAc (70 mL*3). The EtOAc solution was dried (Na2 SO4) and evaporated to dryness. The residue was suspended in 50 mL of CHCl3 and filtered. The yellowish solid was washed with portions of CHCl3 to give 3.40 g of 11. | |
With bromocyane In methanol; chloroform; water; acetonitrile | 2-Amino-5,6-difluorobenzimidazole (11) 2-Amino-5,6-difluorobenzimidazole (11) To a stirred solution of 4.9 mL of 5M BrCN/MeCN in 50 mL of H2 O, was added dropwise a solution of 3.515 g (24.389 mmole) of 10 in 50 mL of MeOH over 20 min. After the addition, stirring was continued at room temperature for 2 h. The reaction mixture was concentrated to ~ 50 mL and was extracted with EtOAc (50 mL*3). The combined EtOAc solution was back washed with 100 mL of H2 O and then discarded. The combined H2 O phase was basified with sat. NaHCO3 solution (precipitation occurred) and was extracted again with EtOAc (70 mL*3). The EtOAc solution was dried (Na2 SO4) and evaporated to dryness. The residue was suspended in 50 mL of CHCl3 and filtered. The yellowish solid was washed with portions of CHCl3 to give 3.40 g of 11. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: pyridine / 4 h / Reflux 2: bromine; trifluoroacetic acid / 2 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: pyridine / 4 h / Reflux 2: bromine; trifluoroacetic acid / 2 h / 20 °C 3: sodium carbonate / water / 0.5 h / Reflux |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: pyridine / 4 h / Reflux 2: bromine; trifluoroacetic acid / 2 h / 20 °C 3: sodium carbonate / water / 0.5 h / Reflux 4: N,N-dimethyl-formamide / 7 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With pyridine for 4h; Reflux; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With pyridine for 6h; Reflux; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
18% | With triethylamine In N,N-dimethyl-formamide at 20℃; for 4h; Inert atmosphere; | 73 Example 73 3-cyclopentyl-N-[10,11-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.02'6]dodeca-1(12),6,8,10-tetraen-3-yl]propanamide (ABR 238925) Example 73 3-cyclopentyl-N-[10,ll-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo- [6.4.0.02'6]dodeca-l(12),6,8,10-tetraen-3-yl]propanamide (ABR 238925) To a stirred solution of 5,6-difluoro-lH-l ,3-benzodiazol-2-amine (100 mg, 0.59 mmol) and methyl (2Z)-2-[(3-cyclopentylpropanoyl)imino]-3,3,3-trifiuoropropanoate (165 mg, 0.59 mmol) in DMF (2 mL) was added triethylamine (79 μ, 0.59 mmol) under nitrogen. The reaction mixture was stirred at room temperature for a further 4 h, concentrated and purified by automated reverse phase HPLC (low pH Method A) to afford the title compound as an off-white solid (44 mg, 18%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | With triethylamine In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere; | 74 Example 74 2-cyclohexyl-N-[10,11-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.02'6]dodeca-1(8),6,9,11-tetraen-3-yl]acetamide (ABR 238929) Example 74 2-cyclohexyl-A'-[10,ll-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.02'6]- dodeca-l(8),6,9,ll-tetraen-3-yl]acetamide (ABR 238929) To a stirred solution of 5,6-difluoro-lH-l ,3-benzodiazol-2-amine (75 mg, 0.44 mmol) and methyl (2Z)-2-[(2-cyclohexylacetyl)imino]-3,3,3-trifluoropropanoate (124 mg, 0.44 mmol) in DMF (2 mL) was added triethylamine (59 μ, 0.44 mmol) under nitrogen. The reaction mixture was stirred at room temperature for 2 h and then concentrated. The crude product was purified by automated reverse phase HPLC (low pH Method A) to afford the desired product as a beige solid (85 mg, 46%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
28% | With triethylamine In N,N-dimethyl-formamide at 20℃; for 3h; Inert atmosphere; | 72 Example 72 N-[10,11-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.02'6]dodeca-1(12),6,8,10-tetraen-3-yl]benzamide (ABR 238928) Example 72 A^-[10,ll-difluoro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.02'6]dodeca- l(12),6,8,10-tetraen-3-yl]benzamide (ABR 238928) To a stirred solution of 5,6-difluoro-lH-l ,3-benzodiazol-2-amine (60 mg, 0.35 mmol) in DMF (2 mL) was added methyl (Z)-benzoylimino-3,3,3-trifiuoropropanoate (92 mg, 0.35 mmol) and triethylamine (47 μ, 0.35 mmol) under nitrogen. The solution was at room temperature for 3 h and then concentrated. The residue was purified by automated reverse phase HPLC (low pH Method A) to afford the title compound as a yellow solid (39 mg, 28%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With recombinant E. coli purine nucleoside phosphorylase; recombinant E. coli uridine phosphorylase In aq. phosphate buffer Enzymatic reaction; | 2-Amino-5,6-difluoro-1-(β-D-ribofuranosyl)benzimidazole (3) Benzimidazole (0.30 g, 1.77mmol, 1 eq.) and uridine (2.17 g, 8.86 mmol, 5 eq.) were dissolved in 20 mM potassiumdihydrogen phosphate buffer (443 ml) at 50°C and pH was adjusted up to 7.0. 4280 e. u. of PNPand 1770 e. u. of UP were added and the reaction was incubated at 50°C. The reaction progress wasmonitored by HPLC.In 20 h the reaction was terminated by addition of ethanol (50%, v/v). The reaction mixture wasconcentrated up to 5 ml and the desired product (3) was isolated by reversed-phase columnchromatography (silica gel C18, Merck, 100 × 20 mm, elution by gradient of ethanol in water, 0 -30%, 600 ml, flow rate 7 ml/min). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | In acetonitrile at 30℃; for 2h; | 2-amino-5,6-difluoro-benzimidazole (2) A solution of 5.86 g (60 mmol, 1.2 eq.) of cyanogen bromide in 100 ml of acetonitrile was added to solution of 7.20 g (50 mmol, 1 eq.) of o-phenylendiamine in 100 ml of acetonitrile at 30°C under stirring. The reaction was kept at room temperature for 2 h, the precipitate was filtered off, suspended in 150 ml H2O and 25 ml of 2M aqueous solution of Na2CO3 was added to the suspension under stirring. The precipitate of 2-amino-5,6-difluoro-benzimidazole (2) was filtered off, dried and purified by flash-chromatography (silica gel, elution by ethanol) followed by recrystallization from acetonitrile. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: recombinant E. coli purine nucleoside phosphorylase; recombinant E. coli uridine phosphorylase / aq. phosphate buffer / pH 7 / Enzymatic reaction 2: N-ethyl-N,N-diisopropylamine / 72 h / 60 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With recombinant E. coli purine nucleoside phosphorylase In aq. phosphate buffer Enzymatic reaction; | 2-Amino-5,6-difluoro-1-(β-D-2'-deoxyribofuranosyl)benzimidazole (4). Benzimidazole (0.10 g,0.60 mmol, 1 eq.) and dIno (0.40 g, 1.78 mmol, 3 eq.) were dissolved in 6 mM potassiumdihydrogen phosphate buffer (296 ml) and pH was adjusted up to 7.0. 130 e. u. of PNP was addedand the reaction was incubated at 50°C. The reaction progress was monitored by HPLC. In 24 h thereaction was terminated by addition of ethanol (50%, v/v). The reaction mixture was concentratedup to 5 ml and the desired product (4) was isolated by reversed-phase column chromatography(silica gel C18, Merck, 100 × 20 mm, elution by gradient of methanol in water, 0 - 50%, 600 ml.flow rate 7 ml/min). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
9% | With nucleoside phosphorylase In aq. phosphate buffer at 55℃; for 48h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / acetonitrile / 168 h / 60 °C 2: N-ethyl-N,N-diisopropylamine; 1,8-diazabicyclo[5.4.0]undec-7-ene / 20 h / 100 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With 1,8-diazabicyclo[5.4.0]undec-7-ene; N-ethyl-N,N-diisopropylamine at 100℃; for 20h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: acetic acid / 4 h / Reflux 2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.08 h / 20 °C 2.2: 2 h / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: acetic acid / 4 h / Reflux 2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.08 h / 20 °C 2.2: 2 h / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: acetic acid / 4 h / Reflux 2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.08 h / 20 °C 2.2: 3 h / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: acetic acid / 4 h / Reflux 2.1: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 0.08 h / 20 °C 2.2: 1 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | In acetic acid for 4h; Reflux; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With dipotassium hydrogenphosphate; (S)-5-benzyl-2-(2,6-dimethoxyphenyl)-6,6-diphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate In acetone at 20℃; Molecular sieve; Inert atmosphere; enantioselective reaction; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With 1-butyl-3-methylimidazolium Tetrafluoroborate In butan-1-ol for 3h; Reflux; | Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidines 5a-l; General Procedure 1 General procedure: A mixture of aminobenzimidazole derivative 3a-c (2 mmol, 1 equiv), benzaldehyde 4a,b (2 mmol, 1 equiv), (E)-N-alkyl-1-(methylthio)-2-nitroethenamine 2a,b (2 mmol, 1 equiv), and [BMIM][BF4] (10 mol%) in n-BuOH was stirred at reflux. The progress of the reaction was monitored by TLC. The reaction mixture was then cooled to r.t., the resulting solid was filtered, and washed exhaustively with EtOH to give the expected product. N-Butyl-3-nitro-4-phenyl-1,4-dihydrobenzo[4,5]imidazo-[1,2-a]pyrimidin-2-amine (5a) The reaction was performed according to the general procedure 1 employing aminobenzimidazole 3a (0.266 g, 2 mmol, 1 equiv), benzaldehyde (4a; 0.200 mL, 2 mmol, 1 equiv), and (E)-N-butyl-1-(methylthio)-2-nitroethenamine (2a; 0.380 g, 2 mmol, 1 equiv) for 3 h; yield: 0.508 g (70%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With 1-butyl-3-methylimidazolium Tetrafluoroborate In butan-1-ol for 3h; Reflux; | Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidines 5a-l; General Procedure 1 General procedure: A mixture of aminobenzimidazole derivative 3a-c (2 mmol, 1 equiv), benzaldehyde 4a,b (2 mmol, 1 equiv), (E)-N-alkyl-1-(methylthio)-2-nitroethenamine 2a,b (2 mmol, 1 equiv), and [BMIM][BF4] (10 mol%) in n-BuOH was stirred at reflux. The progress of the reaction was monitored by TLC. The reaction mixture was then cooled to r.t., the resulting solid was filtered, and washed exhaustively with EtOH to give the expected product. N-Butyl-3-nitro-4-phenyl-1,4-dihydrobenzo[4,5]imidazo-[1,2-a]pyrimidin-2-amine (5a) The reaction was performed according to the general procedure 1 employing aminobenzimidazole 3a (0.266 g, 2 mmol, 1 equiv), benzaldehyde (4a; 0.200 mL, 2 mmol, 1 equiv), and (E)-N-butyl-1-(methylthio)-2-nitroethenamine (2a; 0.380 g, 2 mmol, 1 equiv) for 3 h; yield: 0.508 g (70%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With 1-butyl-3-methylimidazolium Tetrafluoroborate In butan-1-ol for 3h; Reflux; | Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidines 5a-l; General Procedure 1 General procedure: A mixture of aminobenzimidazole derivative 3a-c (2 mmol, 1 equiv), benzaldehyde 4a,b (2 mmol, 1 equiv), (E)-N-alkyl-1-(methylthio)-2-nitroethenamine 2a,b (2 mmol, 1 equiv), and [BMIM][BF4] (10 mol%) in n-BuOH was stirred at reflux. The progress of the reaction was monitored by TLC. The reaction mixture was then cooled to r.t., the resulting solid was filtered, and washed exhaustively with EtOH to give the expected product. N-Butyl-3-nitro-4-phenyl-1,4-dihydrobenzo[4,5]imidazo-[1,2-a]pyrimidin-2-amine (5a) The reaction was performed according to the general procedure 1 employing aminobenzimidazole 3a (0.266 g, 2 mmol, 1 equiv), benzaldehyde (4a; 0.200 mL, 2 mmol, 1 equiv), and (E)-N-butyl-1-(methylthio)-2-nitroethenamine (2a; 0.380 g, 2 mmol, 1 equiv) for 3 h; yield: 0.508 g (70%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With 1-butyl-3-methylimidazolium Tetrafluoroborate In butan-1-ol for 3h; Reflux; | Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidines 5a-l; General Procedure 1 General procedure: A mixture of aminobenzimidazole derivative 3a-c (2 mmol, 1 equiv), benzaldehyde 4a,b (2 mmol, 1 equiv), (E)-N-alkyl-1-(methylthio)-2-nitroethenamine 2a,b (2 mmol, 1 equiv), and [BMIM][BF4] (10 mol%) in n-BuOH was stirred at reflux. The progress of the reaction was monitored by TLC. The reaction mixture was then cooled to r.t., the resulting solid was filtered, and washed exhaustively with EtOH to give the expected product. N-Butyl-3-nitro-4-phenyl-1,4-dihydrobenzo[4,5]imidazo-[1,2-a]pyrimidin-2-amine (5a) The reaction was performed according to the general procedure 1 employing aminobenzimidazole 3a (0.266 g, 2 mmol, 1 equiv), benzaldehyde (4a; 0.200 mL, 2 mmol, 1 equiv), and (E)-N-butyl-1-(methylthio)-2-nitroethenamine (2a; 0.380 g, 2 mmol, 1 equiv) for 3 h; yield: 0.508 g (70%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With pyridine; acetic acid for 5h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With pyridine; acetic acid for 5h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With pyridine; acetic acid for 5h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With pyridine; acetic acid for 5h; Heating; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With pyridine; acetic acid for 5h; Heating; |
[ 30486-73-8 ]
5-Fluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.95
[ 889127-08-6 ]
4,5-Difluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.91
[ 175727-16-9 ]
5,6-Difluoro-2-hydrazinyl-1H-benzo[d]imidazole
Similarity: 0.89
[ 30486-73-8 ]
5-Fluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.95
[ 889127-08-6 ]
4,5-Difluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.91
[ 175727-16-9 ]
5,6-Difluoro-2-hydrazinyl-1H-benzo[d]imidazole
Similarity: 0.89
[ 125908-10-3 ]
5-Fluoro-2-hydrazinyl-1H-benzo[d]imidazole
Similarity: 0.84
[ 30486-73-8 ]
5-Fluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.95
[ 889127-08-6 ]
4,5-Difluoro-1H-benzo[d]imidazol-2-amine
Similarity: 0.91
[ 175727-16-9 ]
5,6-Difluoro-2-hydrazinyl-1H-benzo[d]imidazole
Similarity: 0.89